1. Home
  2. LMNR vs MDWD Comparison

LMNR vs MDWD Comparison

Compare LMNR & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$13.64

Market Cap

264.6M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.58

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
MDWD
Founded
1893
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.6M
238.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
LMNR
MDWD
Price
$13.64
$16.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$20.00
$37.50
AVG Volume (30 Days)
114.4K
88.6K
Earning Date
12-23-2025
11-20-2025
Dividend Yield
2.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,723,000.00
$20,932,000.00
Revenue This Year
N/A
$15.89
Revenue Next Year
$17.27
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.15
52 Week Low
$12.20
$14.14
52 Week High
$23.98
$22.51

Technical Indicators

Market Signals
Indicator
LMNR
MDWD
Relative Strength Index (RSI) 53.07 31.16
Support Level $12.51 $18.55
Resistance Level $13.98 $19.70
Average True Range (ATR) 0.51 0.73
MACD 0.07 -0.21
Stochastic Oscillator 62.19 5.92

Price Performance

Historical Comparison
LMNR
MDWD

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: